Risk of Total Events With Icosapent Ethyl
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk PatientsNew England Journal of Medicine, 2019
- Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk PatientsNew England Journal of Medicine, 2019
- Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaNew England Journal of Medicine, 2019
- FISHing for the Miracle of Eicosapentaenoic AcidNew England Journal of Medicine, 2019
- Transcatheter Mitral-Valve Repair in Patients with Heart FailureNew England Journal of Medicine, 2018
- Percutaneous Repair or Medical Treatment for Secondary Mitral RegurgitationNew England Journal of Medicine, 2018
- Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease RisksJAMA Cardiology, 2018
- Impact of Eicosapentaenoic Acid Treatment on the Fibrous Cap Thickness in Patients with Coronary Atherosclerotic Plaque: An Optical Coherence Tomography StudyJournal of Atherosclerosis and Thrombosis, 2015
- Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheromaAtherosclerosis, 2014
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysisThe Lancet, 2007